Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

Atrial tachycardia and other ectopic atrial rhythms occur when a site outside of the sinus node, but within the atria, creates action potentials faster than the sinus node. This ectopic focus ...

An idioventricular rhythm is very similar to ventricular tachycardia except the ventricular rate is less than 60 beats per minute. All other characteristics of VT apply; this includes the presence ...

Milestone Pharmaceuticals hit another bump in the road in its quest to get Cardamyst approved for paroxysmal supraventricular tachycardia when the FDA issued a Complete Response Letter on Friday.

Milestone in 2023 agreed to sell a royalty interest in etripamil to RTW Investments for $75 million, subject to the company receiving FDA approval of the drug by the end of September 2025. Write to ...

Systems announced the US commercial release of its Ventrax Delivery System. The new delivery system is Merit’s latest ...

The most common mechanism of inappropriate detection in these patients was double counting, which occurred during sinus rhythm, supraventricular tachycardia and nonsustained VT. Double counting ...